...
首页> 外文期刊>Asia-Pacific journal of clinical oncology >Maximum SUV on positron emission tomography and serum CEA level as prognostic factors after curative resection for non-small cell lung cancer
【24h】

Maximum SUV on positron emission tomography and serum CEA level as prognostic factors after curative resection for non-small cell lung cancer

机译:非小细胞肺癌根治性切除后正电子发射断层扫描上的最大SUV和血清CEA水平是预后因素

获取原文
获取原文并翻译 | 示例
           

摘要

Aims: The relationship between the maximum standardized uptake values (SUVmax) on positron emission tomography (PET) and serum carcinoembryonic antigen (CEA) level in non-small cell lung cancer (NSCLC) patients was investigated. Methods: Consecutively, 197 surgically resected NSCLC patients with preoperative staging including serum CEA and PET were reviewed retrospectively. Results: When patients were subdivided into two groups based on the median value of the SUVmax (6.6), the 5-year survival of patients with a high SUVmax was 63.20%, which was significantly worse than patients with a low SUVmax (87.29%, P = 0.0004). The 5-year survival of patients with normal and high serum CEA level was 82.70 and 51.08%, respectively (P < 0.0001). Univariate and multivariate analyses indicated the independent prognostic impact of the SUVmax and serum CEA level. Patients with both low SUVmax and normal serum CEA level had favorable prognosis, whereas those with both high SUVmax and high serum CEA level had poor prognosis. Conclusion: Preoperative SUVmax and serum CEA level are independent prognostic factors for survival in NSCLC. The combined use of preoperative SUVmax and serum CEA level might be a better prognostic indicator.
机译:目的:研究非小细胞肺癌(NSCLC)患者正电子发射断层显像(PET)的最大标准摄取值(SUVmax)与血清癌胚抗原(CEA)水平之间的关系。方法:回顾性分析197例手术切除的NSCLC患者的术前分期,包括血清CEA和PET。结果:将患者根据SUVmax的中位数(6.6)分为两组时,高SUVmax的患者的5年生存率为63.20%,明显低于低SUVmax的患者(87.29%, P = 0.0004)。血清CEA水平正常和高的患者的5年生存率分别为82.70和51.08%(P <0.0001)。单因素和多因素分析表明SUVmax和血清CEA水平具有独立的预后影响。 SUVmax较低且血清CEA水平正常的患者预后良好,而SUVmax较高且血清CEA水平高的患者预后较差。结论:术前SUVmax和血清CEA水平是NSCLC生存的独立预后因素。术前联合使用SUVmax和血清CEA水平可能是更好的预后指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号